Sanuwave Health Inc. SNWV
5.04
0.19
3.92%
as of 25 Sep
- Market cap
- $41.7M
- P/E
- 3.0×
Follow SNWV
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 0.00 | 22.70 |
P/S ratio |
1.42 | 1.42 | 1.42 | 1.42 | 1.42 | 1.42 | 1.42 | 1.42 | 3.15 | 5.80 |
P/FCF ratio |
117.92 | 117.92 | 117.92 | 117.92 | 117.92 | 117.92 | 117.92 | 117.92 | 52.24 | 34.96 |
P/Operating CF |
32.38 | 32.38 | 32.38 | 32.38 | 32.38 | 32.38 | 32.38 | 32.38 | 138.52 | 76.99 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 157.84 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 3.61 | 6.03 |
EV/EBITDA |
5.74 | 5.74 | 5.74 | 5.74 | 5.74 | 5.74 | 5.74 | 5.74 | 11.20 | 34.53 |
EV/Operating CF |
148.15 | 148.15 | 148.15 | 148.15 | 148.15 | 148.15 | 148.15 | 148.15 | 47.98 | 68.51 |
EV/FCF |
180.56 | 180.56 | 180.56 | 180.56 | 180.56 | 180.56 | 180.56 | 180.56 | 59.94 | 36.33 |
Quick Ratio |
0.08 | 0.08 | 0.04 | 0.15 | 0.13 | 0.05 | 0.09 | 0.08 | 0.30 | 0.97 |
Current Ratio |
0.12 | 0.11 | 0.07 | 0.20 | 0.22 | 0.08 | 0.11 | 0.15 | 0.41 | 1.38 |
Net Debt/EBITDA |
0.03 | (0.03) | (1.19) | 0.11 | (0.09) | (1.24) | (4.35) | 2.85 | 1.44 | 1.30 |
Debt/Assets |
4.72% | 64.58% | 460.12% | 23.64% | 19.39% | 67.77% | 72.54% | 101.95% | 84.24% | 58.81% |
Debt/Equity |
(0.01) | (0.08) | (0.35) | (0.08) | (0.33) | (0.32) | (0.35) | (0.53) | (1.61) | 13.56 |
Asset Turnover |
1.40 | 0.65 | 1.51 | 0.45 | 0.31 | 0.62 | 0.87 | 0.96 | 1.24 | 1.31 |
Operating CF/Net income |
0.50 | 0.28 | 0.31 | 0.61 | 0.41 | 0.24 | 1.67 | 0.18 | (0.07) | 0.33 |
Capex/Depreciation |
(0.02) | 0.00 | (0.01) | (0.76) | (0.04) | (0.12) | 0.06 | 0.00 | (0.07) | 1.25 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 100.69% | 65.96% | 92.18% | 82.06% | 260.18% | 103.50% | 25.74% | 61.31% | 112.20% | (166.66%) | |
| (655.94%) | (484.99%) | (946.99%) | (457.48%) | (234.29%) | (130.91%) | (53.48%) | (122.05%) | (125.95%) | 35.02% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 26.60% |
Return on Tangible Assets |
92.98% | 55.97% | 75.89% | 106.24% | 111.38% | 53.61% | 19.52% | 47.76% | 123.80% | 134.97% |
Average Days of Receivables |
122.22 | 75.37 | 46.32 | 26.79 | 211.96 | 67.75 | 87.84 | 59.30 | 37.23 | 44.93 |
Research and Development Expense of Revenue |
82.01% | 175.02% | 53.06% | 114.89% | 30.71% | 8.46% | 3.39% | 2.84% | 2.06% | 3.07% |
Selling, General and Administrative Expense of Revenue |
194.30% | 406.82% | 396.34% | 780.70% | 465.44% | 155.89% | 119.64% | 66.54% | 58.96% | 60.82% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.60 | 0.70 | 0.62 | 0.52 | 0.36 | 0.28 |
Share Based Compensation of Revenue |
56.52% | 129.86% | 188.70% | 35.18% | 64.41% | 0.00% | 5.30% | 1.10% | 4.64% | 11.01% |
Graham Net Nets |
(1.74) | (1.74) | (1.74) | (1.74) | (1.74) | (1.74) | (1.74) | (1.74) | (0.27) | (0.04) |
Graham Number |
109.05 | 93.37 | 155.68 | 87.02 | 94.38 | 110.45 | 66.12 | 71.41 | 23.58 | 2.36 |
Earnings Yield |
40.22% | 40.22% | 40.22% | 40.22% | 40.22% | 40.22% | 40.22% | 40.22% | (30.35%) | 4.40% |
Free Cash Flow Yield |
0.85% | 0.85% | 0.85% | 0.85% | 0.85% | 0.85% | 0.85% | 0.85% | 1.91% | 2.86% |
Revenue per Share |
4.74 | 1.97 | 4.58 | 1.87 | 3.97 | 9.30 | 11.28 | 9.64 | 7.31 | 5.14 |
Operating CF per Share |
(11.01) | (4.08) | (8.97) | (11.66) | (12.46) | (4.58) | (11.57) | (2.14) | 0.55 | 0.45 |
Capex per Share |
(0.03) | 0.00 | (0.11) | (0.10) | (0.05) | (0.38) | 0.22 | 0.01 | (0.11) | 0.40 |
Free Cash Flow per Share |
(11.04) | (4.08) | (9.07) | (11.76) | (12.51) | (4.96) | (11.35) | (2.13) | 0.44 | 0.85 |
Cash per Share |
0.46 | 1.95 | 0.90 | 3.20 | 2.39 | 0.44 | 0.78 | 0.85 | 2.29 | 1.40 |
Shareholders Equity per Share |
(23.78) | (26.36) | (38.03) | (18.31) | (13.44) | (27.84) | (27.64) | (20.40) | (3.54) | 0.19 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(23.78) | (26.36) | (38.03) | (18.31) | (13.44) | (27.84) | (27.64) | (20.40) | (3.54) | 0.19 |
Free Cash Flow |
(3.21) | (1.53) | (3.66) | (6.46) | (12.77) | (6.94) | (16.84) | (4.52) | 1.97 | 7.31 |
Working Capital |
(7.00) | (9.96) | (15.40) | (9.91) | (28.25) | (51.86) | (53.59) | (54.97) | (27.03) | 6.78 |
Capital Expenditures |
(0.01) | — | (0.04) | (0.05) | (0.05) | (0.53) | 0.33 | 0.02 | (0.49) | 3.43 |
Net Current Asset Value |
(7.00) | (9.96) | (15.45) | (10.94) | (28.82) | (53.18) | (54.26) | (55.81) | (27.52) | (11.10) |
EV/EBIT |
16.16 | 16.16 | 16.16 | 16.16 | 16.16 | 16.16 | 16.16 | 16.16 | 30.61 | 53.70 |
Capex to Sales |
0.01 | 0.00 | 0.02 | 0.05 | 0.01 | 0.04 | (0.02) | 0.00 | 0.02 | (0.08) |
Net Profit Margin |
(467.92%) | (749.88%) | (628.69%) | (1,013.88%) | (762.56%) | (209.52%) | (61.48%) | (126.52%) | (101.38%) | 26.82% |
Price to Operating Income |
10.55 | 10.55 | 10.55 | 10.55 | 10.55 | 10.55 | 10.55 | 10.55 | 26.68 | 51.68 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
7.59 | 9.36 | 37.79 | 0.76 | 3.18 | 4.41 | 6.89 | 8.46 | 22.00 | 1.39 |
Cash ROIC |
48.68% | 19.09% | 38.64% | 86.69% | 193.47% | 28.85% | 70.85% | 29.56% | 10.86% | 5.36% |
Accounts Receivable Turnover |
5.14 | 2.41 | 9.55 | 6.63 | 3.34 | 5.45 | 5.20 | 5.56 | 9.83 | 10.07 |
Accounts Payable Turnover |
0.92 | 0.22 | 0.45 | 0.36 | 0.39 | 0.82 | 0.72 | 1.19 | 1.71 | 2.89 |
Inventory Turnover |
2.19 | 1.04 | 2.35 | 1.20 | 0.66 | 2.50 | 4.54 | 3.16 | 2.28 | 2.00 |
Average Days of Payables |
460.53 | 2,257.12 | 837.97 | 974.91 | 1,399.06 | 559.58 | 370.82 | 345.04 | 168.32 | 117.70 |
Days of Inventory on Hand |
149.85 | 349.16 | 188.26 | 367.78 | 928.52 | 76.13 | 73.15 | 178.48 | 187.33 | 214.83 |
Average Receivables |
0.27 | 0.31 | 0.19 | 0.16 | 1.22 | 2.39 | 3.22 | 3.67 | 3.32 | 4.38 |
Average Payables |
0.61 | 1.10 | 1.54 | 1.52 | 2.95 | 6.05 | 6.02 | 5.05 | 4.72 | 3.49 |
Average Inventory |
0.26 | 0.23 | 0.29 | 0.45 | 1.75 | 2.00 | 0.95 | 1.91 | 3.55 | 5.04 |
Average Assets |
0.98 | 1.14 | 1.23 | 2.28 | 13.20 | 20.82 | 19.25 | 21.14 | 26.27 | 33.73 |
Average Common Equity |
(6.39) | (8.40) | (12.62) | (12.71) | (11.89) | (26.34) | (39.98) | (42.09) | (29.49) | (7.09) |
Columns are period end dates